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Insurer
Open
Procedure EVI
AKA/
BKA
Admission
For
Gangrene
Private pay (PP) 21% 221% 162% 214% 213%
Medicare 68% 217% 1101% 211% 25%
Medicaid 9% 224% 1115% 214% 227%
Uninsured (UI) 1% 18% 138% 17% 135%
Significance P  .001 P  .03 P  .04 P  .001
AKA/BKA; Above the knee amputation/below the knee amputation; EVI,
endovascular intervention.
Hydrogen Sulfide Prevents Ischemia-Reperfusion Injury in Muscle
even when Delivered in the Post-ischemic Period
Henderson PW, Singh SP, Weinstein AL, Nagineni V, Spector JA
Objectives: Ischemia-reperfusion injury (IRI) is an unavoidable con-
sequence of revascularization following acute vascular occlusion. Hydrogen
sulfide (H2S) is now recognized as an endogenous signaling molecule, and
recent work from our lab has shown that H2S mitigates IRI in muscle when
delivered prior to the onset of ischemia. The purpose of this study was to
determine whether H2S confers a similar protective effect when delivered
after an ischemic event has occurred.
Methods:Nine C57/BL6 mice underwent three hours of tourniquet-
induced hind limb ischemia and were randomized to three groups: no H2S,
10M intravenous H2S delivered one minute prior to reperfusion, and
10M H2S delivered 20 minutes prior to reperfusion. After three hours of
reperfusion, the gastrocnemius and soleus muscles were harvested bilater-
ally. Sections were stained with hematoxylin and eosin (H&E) and subjected
to a terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL) assay. Values are reported as mean SE, and student t tests were
performed compared to non-H2S-treated mice. Statistical significance was
set at P  .05.
Results:Upon histologic examination, ischemic tissue from non-H2S-
treated mice had architectural changes including extracellular edema and
intracellular vacuolization; tissue from mice treated with H2S one minute
prior to reperfusion was similar in appearance (Fig). Ischemic tissue from
mice treated with H2S 20 minutes prior to reperfusion showed no evidence
of architectural changes. Non-ischemic tissue treated with H2S was not
different in appearance from non-ischemic, non-treated tissue. The percent-
age of apoptotic cells was significantly reduced by treating mice with H2S 20
minutes prior to reperfusion, but not when H2S was delivered one minute
prior (18.1%  11.0% in non-HS-treated mice, 1.8%  1.4% [P  .026] in
mice treated with H2S 20 minutes prior to reperfusion, and 16.0%  7.7%
[P  .771] in mice treated with H2S one minute prior to reperfusion).
Conclusions: After an ischemic insult has occurred, H2S protects
against IRI when delivered 20 minutes, but not one minute, prior to
reperfusion. This suggests the mechanism by which H2S functions requires
equilibration prior to reperfusion. The absence of injury in non-ischemic
H2S-treated tissue suggests that H2S is non-toxic at the dose tested in this
study (10 M). We conclude that H2S may have clinical application as a
component of therapeutic revascularization regimens.
Endothelial Cells with Eph B4 Heterozygous Knockdown: A Novel
Model for Vein Graft Adaptation
Feigel A, Muto A, Fancher T, et al
Objectives: Vein graft adaptation (VGA) is characterized by vein wall
thickening, a complex process requiring cell proliferation and migration. We
have previously shown that VGA is also associated with loss of the venous
determinant Eph-B4. To study molecular mechanisms that mediate VGA,
we developed a novel in vitro model of VGA.Methods: Aortic interposition grafts were examined using veins from
wild type (WT) and Eph-B4 heterozygous knockout (Eph-B4-KO) mice.Endothelial cells (EC) were isolated from both WT and Eph-B4-KO mice.
Cell proliferation was directly counted. Quantitative polymerase chain reac-
tion (qPCR) was used to evaluate basal mRNA expression. Western blot was
used to evaluate protein levels. Cell migration was evaluated using a Boyden
chamber.
Results: Vein grafts from Eph-B4-KO mice had 50% increased intimal
thickness compared with vein grafts from WT mice (P  .01). Under basal
conditions, Eph-B4-KO cells proliferated 41% more slowly than WT EC
(P  .029), and 43% more slowly when stimulated with Ephrin-B2/Fc.
Basal protein expression of Akt was 29% higher, and vascular endothelial
growth factor (VEGF)-A was 28% lower in Eph-B4-KO cells compared with
WT EC. Under direct stimulation, levels of phosphorylated AKT and
phosphorylated ERK 1/2 were greater in Eph-B4-KO cells. qPCR con-
firmed 49% less VEGF-A mRNA expression in Eph-B4-KO cells. Eph-
B4-KO cells had 60% reduced cell migration in response to Ephrin-B2/Fc
(P  .005).
Conclusions: EC isolated from Eph-B4-KO mice serve as a novel in
vitro model of VGA. This model suggests that reduced Eph-B4 expression
during VGAmay bemediated by upstream signals such as VEGF-A as well as
downstream pathways such as Akt.
The Effect of Tortuosity on Five Different Cerebral Protection Devices
in an Ex-vivo Model
Shah AR, Lipsitz EC, Scher L, et al
Objectives: To compare the efficacy and ease of deployment for five
currently available cerebral protection devices at varying degrees of tortuos-
ity.
Methods: An ex-vivo study using procured canine carotid arteries was
performed using an open flow model with three anatomical variants (non-
tortuous, mildly tortuous, and severely tortuous) and two embolic particle
sizes (250 and 425 microns). Cerebral protection devices (Accunet
[Guidant Corporation, Santa Clara, Calif], Angioguard [Cordis, Miami
Lakes, Fla], Emboshield [Abbott Laboratories, Abbott Park, III], Filterwire
EZ [Boston Scientific Corporation, Natick, Mass], and SpideRX [ev3, Inc,
Plymouth, Minn]) were placed under fluoroscopy at the point of maximal
inflection in the case of tortuous vessels. A total of 1.5 mg ( 0.05 mg) of
polyvinyl alcohol (PVA) particles of either size was injected into the carotid
system proximal to each of five protection devices at each of the three
degrees of tortuosity. Particles captured by the filters were weighted and
compared with the weight of the particles collected in the effluent filter (not
captured). The time taken to deploy each device at this position was
recorded.
Results: The percent capture for each of the five filters at each degree
of tortuosity using 425 micron particles is shown in the Fig. Similar results
were obtained for the 250 micron particles. Filterwire EZ and SpiderX were
deployed within the 26 to 27 second range. All others were deployed
between 30 and 36 seconds.
Conclusions: No filter completely prevented embolization. Filterwire
EZ, Accunet, and Angioguard exhibited the highest capture rates in straight
anatomy. Angioguard was the most efficacious filter in tortuous anatomy.
Increasing tortuosity had a significant negative impact on all filters. Filter-
wire EZ and SpiderX had the best trackability in tortuous vessels using this
model.
Mechanical Stimulation of HUVEC: Different Flow Patterns have
Differential Effects on TF Expression
Nixon AM, Rochier A, Yamashita N, Sumpio BE
Objectives: Human umbilical vein endothelial cells (HUVECs) are
known to respond differentially to various mechanical stimuli, and these
different responses maybe involved in atherogenesis. Here we investigated
the differential effects of different flow patterns, such as laminar flow (LF)
and orbital shear stress (OSS), on the expression of tissue factor (TF).
Methods:HUVECs were seeded on fibronectin coated glass slides and
selectively in the periphery of gelatin coated culture dishes. When HUVECs
on slides reached confluence, they were exposed to two, four, or six hours of
LF (14 dynes/cm2). HUVECs in culture dishes were exposed to the same
